Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group

Maurer, M. S., Dunnmon, P., Fontana, M., Quarta, C. C., Prasad, K., Witteles, R. M., Rapezzi, C., Signorovitch, J., Lousada, I., & Merlini, G. (2022). Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group. Circulation: Heart Failure, 15(6). https://doi.org/10.1161/circheartfailure.121.009038
Authors:
Mathew S. Maurer
Preston Dunnmon
Mariana Fontana
Cristina Candida Quarta
Krishna Prasad
Ronald M. Witteles
Claudio Rapezzi
James Signorovitch
Isabelle Lousada
Giampaolo Merlini
Affiliated Authors:
Mathew S. Maurer
Subjects:
Amyloidosis (MeSH)
Heart Failure (MeSH)
Immunoglobulin Light-chain Amyloidosis (MeSH)
Author Keywords:
amyloidosis
clinical trial
immunoglobulin light chains
prognosis
progression-free survival
elink
Publication Type:
Article
Unique ID:
10.1161/CIRCHEARTFAILURE.121.009038
PMID:
35331001
DOI:
10.1161/CIRCHEARTFAILURE.121.009038
Journal:
Circulation: Heart Failure
Publication Date:
Data Source:
Web of Science
Source Link:
View Web of Science Record
View PubMed Record

Record Created: